An Introduction to Bone Disorders
Osteoporosis medications aim to markedly reduce the occurrence of fractures but can have rare and serious adverse effects. The introduction of new drug classes, including an anti-sclerostin monoclonal antibody and a parathyroid hormone-related peptide analogue, into the treatment landscape, offers new options to patients. The potential for cell-based therapies and drugs that target the elimination of senescent cells in the bone microenvironment are currently being investigated.
Browse our gallery of video highlights and short articles from the conference hub, providing the latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Bone Disorders Content
Lisa Sarfaty: Exploring and addressing inequities in rare diseases
Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization for Rare Disorders) and explore ways in which they could be tackled. Questions Could you […]
Lisa Sarfaty: Help support Rare Disease Day
Our society partner, NORD (The National Organization for Rare Disorder) has planned several initiatives to support this year’s Rare Disease Day on 28 February. These activities are aimed at raising awareness about rare diseases and the challenges faced by people living with these conditions. In this video, Lisa Sarfaty, NORD’s VP of Communication and Engagement, […]
Paediatric growth patterns and their impact on health: Achondroplasia in focus
Watch experts in paediatric endocrinology discuss the physiology of normal and abnormal bone growth, and the assessment and treatment of achondroplasia.
- Explain how the mechanisms behind various bone growth control systems contribute to bone health and bone abnormalities
- Use appropriate growth charts to detect abnormal growth patterns in children
- Summarize the linear growth patterns, and physical and radiographic findings indicative of achondroplasia, and the impact of emerging treatments
Andrea R Genazzani, WCO IOF-ESCEO 2022: Hormone Replacement Therapy for Bone Loss Prevention Post Menopause (Part 2)
It was a pleasure to talk with Dr. Andrea R Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to find out when, in whom and for how long hormone replacement therapy should be administered for bone loss prevention post-menopause. ‘Hormone Replacement Therapy in post-menopause for bone loss prevention: when, how and for […]
Andrea R. Genazzani, WCO IOF-ESCEO 2022: Hormone Replacement Therapy for Bone Loss Prevention Post Menopause (Part 1)
touchENDOCRINOLOGY were delighted to catch up with Dr. Andrea R. Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to discuss the health burden of osteoporosis in post-menopausal women and how HRT could be used as a prevention strategy. ‘Hormone Replacement Therapy in post-menopause for bone loss prevention: when, how and for how […]
Michael R. McClung, WCO IOF-ESCEO 2022: Therapeutic Updates in Osteoporosis
We were delighted to talk with Dr Michael R. McClung (Oregon Osteoporosis Center, Portland, OR, USA) around the current unmet needs and standard of care for osteoporosis and the therapeutic targets currently being investigated that could lead to new drug approvals. ‘Can we expect new chemical entities for the management of osteoporosis in the coming […]
Richard Keen, Rare Disease Day 2022: Rare bone diseases – Diagnosis, management and patient quality of life
Dr Richard Keen (Director, Centre for Metabolic Bone Disease, Royal National Orthopaedic Hospital, Stanmore, UK) joins us for Rare Disease Day to discuss the spectrum of rare bone disorders, the challenges of diagnosis, and the impact on patient quality of life. Touch Medical Media is supporting Rare Disease Day (28 February 2022) to shine a […]
Ethan Crough, Rare Disease Day 2022: Living with achondroplasia – Celebrating diversity and increasing awareness
Ethan Crough, a middle school technology education teacher, joins us for Rare Disease Day to celebrate diversity as a man living with achondroplasia. Ethan discusses his experiences of living with achondroplasia and highlights useful resources such as Little People of America, which provide support for people of short stature and their families. Touch Medical Media […]
Nicola Veronese, WCO21: Pharma-grade Chondroitin Sulfate in Osteoarthritis Treatment
touchIMMUNOLOGY joins Professor Nicola Veronese (University of Padova, Italy) at WCO21 to discuss the efficacy, safety and quality of pharma-grade chondroitin sulfate in osteoarthritis treatment. Questions 1. What is the rationale for the use of highly purified chondroitin sulfate (hpCS) in osteoarthritis treatment? (00:12-01:05) 2. Could you tell us a little about your recent literature […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!